Developing new methods for creating important chemical compounds for drug development
Hyster (Rivas-Souchet) Diversity Supplement
This study is working on a new method to make nitriles, which are important for creating better medicines, so patients might eventually get new drugs that work better and have fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Princeton University NIH-funded |
| Lab location | 1 site (Princeton, UNITED STATES) |
| Project ID | NIH-11045279 on NIH RePORTER |
What this research studies
This research focuses on creating a new way to synthesize nitriles, which are important components in many biologically active molecules. By using biocatalysis and directed evolution, the team aims to improve the efficiency and selectivity of these chemical reactions. Patients may benefit from this work as it could lead to the development of new drugs with better efficacy and fewer side effects. The research involves optimizing conditions for these reactions and exploring the mechanisms behind them.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new drugs developed from nitrile compounds.
Not a fit: Patients who are not seeking new treatment options or those with conditions unrelated to the compounds being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and safer drugs for various medical conditions.
How similar studies have performed: Other research in biocatalysis and directed evolution has shown promising results, indicating that this approach could be effective in drug development.
Where this research is happening
Princeton, UNITED STATES
- Princeton University — Princeton, United States (Active)
Researchers
- Principal investigator: Hyster, Todd Kurt — Princeton University
- Study coordinator: Hyster, Todd Kurt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.